^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

HJC0152

i
Other names: HJC0152
Associations
Trials
Company:
The University of Texas, Tianjin Medical University Cancer Institute and Hospital, UT MD Anderson Cancer Center
Drug class:
STAT3 inhibitor, Glucose metabolism modulator
Associations
Trials